THE FPG PROTEIN, A DNA-REPAIR ENZYME, IS INHIBITED BY THE BIOMEDIATORNITRIC-OXIDE IN-VITRO AND IN-VIVO

Authors
Citation
Da. Wink et J. Laval, THE FPG PROTEIN, A DNA-REPAIR ENZYME, IS INHIBITED BY THE BIOMEDIATORNITRIC-OXIDE IN-VITRO AND IN-VIVO, Carcinogenesis, 15(10), 1994, pp. 2125-2129
Citations number
35
Categorie Soggetti
Oncology
Journal title
ISSN journal
01433334
Volume
15
Issue
10
Year of publication
1994
Pages
2125 - 2129
Database
ISI
SICI code
0143-3334(1994)15:10<2125:TFPADE>2.0.ZU;2-L
Abstract
Nitric oxide has been shown to be a mediator molecule in the regulatio n of many physiological functions. However, this small diatomic molecu le in the presence of O-2 generates reactive intermediates which modif y DNA bases and inactive enzymes at high concentrations (100 mu M). We report that NO generated by 1,1-diethyl-2-hydroxy-2-nitrosohydrazine (DEA/NO, Et(2)NN(O)NO-Na+), a compound known to release NO in a predic table manner, caused irreversible damage at physiological concentratio ns to the zinc finger-containing DNA repair enzyme formamidopyrimidine -DNA glycolyase (Fpg protein). The inhibition of the enzyme activity w as DEA/NO dose and time dependent with IC(50)s with respect to total N O released from this compound of approximate to 110 and approximate to 120 mu mol/l respectively. This inhibitory effect by NO was not rever sible over time in the presence of reducing agents and/or Zn2+. Nitrit e and diethylamine, the nitrogenous products of the decomposition of D EA/NO, did not inhibit the enzyme. The presence of 500 mu g/ml bovine serum albumin did not protect the protein from the inhibitory effects of DEA/NO, however, the presence of 10 mM cysteine did dramatically ab ate the inhibition of the Fpg protein by DEA/NO. Other DNA glycosylase s tested were not inhibited by exposure to these concentrations of NO. These results, together with reports of site-directed mutagenesis of this protein, suggest that the cysteine residues contained within the zinc finger motif of the Fpg protein are the primary sites of NO inter action. Our studies were then extended to intact cells. The Fpg protei n activity was decreased following treatment in vivo when Escherichia coil MH321 (acr A(-)) cells were treated with DEA/NO. Furthermore, the Fapy-DNA glycosylase activity in H4 cells, a rat hepatoma line, was d ecreased when intact cells were incubated with DEA/NO.